These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 436739

  • 1. The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors.
    Sato B, Spomer W, Huseby RA, Samuels LT.
    Endocrinology; 1979 Mar; 104(3):822-31. PubMed ID: 436739
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y, Sato B, Noma K, Kishimoto S, Koizumi K, Aono T, Matsumoto K.
    Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
    [Abstract] [Full Text] [Related]

  • 3. Evidence of a small molecule in mouse Leydig cell tumors which inhibits the conversion of estrogen receptor from 4S to 5S.
    Sato B, Huseby RA, Samuels LT.
    Endocrinology; 1978 Feb; 102(2):545-55. PubMed ID: 743977
    [Abstract] [Full Text] [Related]

  • 4. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors.
    Navickis RJ, Shimkin MB, Hsueh AJ.
    Cancer Res; 1981 May; 41(5):1646-51. PubMed ID: 6260347
    [Abstract] [Full Text] [Related]

  • 5. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites.
    Metzger DA, Curtis S, Korach KS.
    Endocrinology; 1991 Apr; 128(4):1785-91. PubMed ID: 2004602
    [Abstract] [Full Text] [Related]

  • 6. Presence of two types of estrogen binding sites in mouse testis.
    Terakawa N, Aono T, Matsumoto K.
    J Steroid Biochem; 1985 Jan; 22(1):147-50. PubMed ID: 3974225
    [Abstract] [Full Text] [Related]

  • 7. Steroid receptor forms and their interaction with cytoplasmic modulators.
    Sato B, Nishizawa Y, Maeda Y, Noma K, Honma T, Matsumoto K.
    J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
    [Abstract] [Full Text] [Related]

  • 8. Tissue and species specificity of unmasked nuclear acceptor sites for the estrogen receptor of Squalus testes.
    Ruh MF, Singh RK, Mak P, Callard GV.
    Endocrinology; 1986 Feb; 118(2):811-8. PubMed ID: 3943492
    [Abstract] [Full Text] [Related]

  • 9. Properties of the estrogen receptor in the human oviduct and its interaction with ethinylestradiol and mestranol in vitro.
    Muechler EK, Kohler D.
    J Clin Endocrinol Metab; 1980 Nov; 51(5):962-7. PubMed ID: 7419693
    [Abstract] [Full Text] [Related]

  • 10. Estrogen binding component of mouse Leydig cell tumor: an in vitro conversion from nonreceptor to receptor-like molecule.
    Sato B, Maeda Y, Noma K, Matsumoto K, Yamamura Y.
    Endocrinology; 1981 Feb; 108(2):612-9. PubMed ID: 7449741
    [No Abstract] [Full Text] [Related]

  • 11. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS, Baudendistel LJ.
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [Abstract] [Full Text] [Related]

  • 12. Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia.
    Juriansz RL, Huseby RA, Wilcox RB.
    Cancer Res; 1988 Jan 01; 48(1):14-8. PubMed ID: 3334987
    [Abstract] [Full Text] [Related]

  • 13. The fetal thymus of guinea pig as an estrogen target organ.
    Screpanti I, Gulino A, Pasqualini JR.
    Endocrinology; 1982 Nov 01; 111(5):1552-61. PubMed ID: 7128525
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B, Happe HK.
    Endocrinology; 1986 Aug 01; 119(2):904-15. PubMed ID: 3732150
    [Abstract] [Full Text] [Related]

  • 15. [Estrogen receptor in human endometrium--energy requirement, stability and subunit structure-- (author's transl)].
    Ozaki M, Kurachi K.
    Nihon Naibunpi Gakkai Zasshi; 1976 Aug 20; 52(8):774-83. PubMed ID: 1035170
    [Abstract] [Full Text] [Related]

  • 16. Conversion of estrogen receptor from a state with low affinity for estradiol into a state of higher affinity does not require 4S to 5S dimerization.
    Müller RE, Traish AM, Hirota T, Bercel E, Wotiz HH.
    Endocrinology; 1985 Jan 20; 116(1):337-45. PubMed ID: 2981069
    [Abstract] [Full Text] [Related]

  • 17. A high-affinity estrogen-binding protein in rat placental trophoblast.
    McCormack SA, Glasser SR.
    Endocrinology; 1976 Sep 20; 99(3):701-12. PubMed ID: 182465
    [Abstract] [Full Text] [Related]

  • 18. Multiple estrogen binding sites in the uterus: stereochemistry of receptor and non-receptor binding of diethylstilbestrol and its metabolites.
    Chae K, Johnston SH, Korach KS.
    J Steroid Biochem Mol Biol; 1991 Jan 20; 38(1):35-42. PubMed ID: 1997122
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of the dextran-coated charcoal assay for estradiol receptor in breast cancer preparations.
    Shafie S, Brooks SC.
    J Lab Clin Med; 1979 Nov 20; 94(5):784-98. PubMed ID: 501205
    [Abstract] [Full Text] [Related]

  • 20. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
    Nishizawa Y, Maeda Y, Noma K, Sato B, Matsumoto K, Yamamura Y.
    Endocrinology; 1981 Nov 20; 109(5):1463-72. PubMed ID: 6795027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.